enGene Holdings Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ENGN, ENGNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
4868 Rue Levy, Suite 220, Saint Laurent, Quebec, Canada

Insiders trading volume in the past year

enGene Holdings Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fonds De Solidarite Des Travailleurs Du Quebec 10%+ Owner $45.5M -$788K -1.7% Apr 18, 2024
Lumira Capital Investment Management Inc. 10%+ Owner $38.5M Feb 20, 2024
Gerald A. Brunk Director $2.39M Jun 15, 2024
Anthony T. Cheung Chief Technology Officer $1.03M Mar 18, 2024
Richard M. Glickman Director $22K Jun 15, 2024
Bvf Partners L P/Il 10%+ Owner Oct 31, 2023
Jason D. Hanson Chief Executive Officer, Director Oct 31, 2023
Richard P. Bryce Chief Medical Officer Nov 30, 2023
Forbion Growth Sponsor FEAC I B.V. 10%+ Owner Oct 31, 2023
James C. Sullivan Chief Scientific Officer Oct 31, 2023
Forbion Capital Fund III Cooperatief U.A. 10%+ Owner Oct 31, 2023
D. Ryan Daws Chief Financial Officer Nov 30, 2023
Lota S. Zoth Director Jun 15, 2024
Alexander Julian Nichols Pres. & Chief Operating Ofc. Oct 31, 2023
Jasper Bos Director Jun 15, 2024
Lee Giguere Chief Legal Ofc. and Corp Secy Mar 15, 2024
Alexandre Jean-Rene Erwan Grassin Int. Chief Financial Officer Oct 31, 2023
Wouter Joustra Director Jun 15, 2024
Paul J. Hastings Director Jun 15, 2024
Ronald Harold Wilfred Cooper Chief Executive Officer, Director Jul 22, 2024
Raj Som Pruthi Chief Medical Officer Jul 24, 2024

Recent Insider Transactions by Companies or Individuals for enGene Holdings Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.